Archive of All Online Issues
January 1995 - Present
| Current Issue: | Recent Issues: | ||
|---|---|---|---|
Vol. 16, Num. 3 |
Vol. 16, Num. 2 |
Vol. 16, Num. 1 |
Vol. 15, Num. 24 |
| Full Text and Abstracts: January 1999 - Present | ||||||||||
| 2010s | 2010 | - | - | - | - | - | - | - | - | - |
| 2000s | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 |
| 1990s | - | - | - | - | - | - | - | - | - | 1999 |
| Full Text (PDF Format Only) and Abstracts: January 1995 - December 1998 | ||||||||||
| 1990s | - | - | - | - | - | 1995 | 1996 | 1997 | 1998 | - |
Most
-
Read
- Hyperthermic Isolated Limb Perfusion with Tumor Necrosis Factor-{{alpha}} and Melphalan in Patients with Locally Advanced Soft Tissue Sarcomas: Treatment Response and Clinical Outcome Related to Changes in Proliferation and Apoptosis
- Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 Growth Factor Receptors and Their Ligands, Neuregulin-1 {{alpha}}, Neuregulin-1 {{beta}}, and Betacellulin, in Normal Endometrium and Endometrial Cancer
- Consideration of QT/QTc Interval Data in a Phase I Study in Patients with Advanced Cancer
- Imaging of Soft-Tissue Tumors Using L-3-[Iodine-123]Iodo-{{alpha}}-methyl-tyrosine Single Photon Emission Computed Tomography: Comparison with Proliferative and Mitotic Activity, Cellularity, and Vascularity
- Inhibition of PI3K and MEK: It Is All about Combinations and Biomarkers
-
Cited
- Antitumor Effect and Potentiation of Cytotoxic Drugs Activity in Human Cancer Cells by ZD-1839 (Iressa), an Epidermal Growth Factor Receptor-selective Tyrosine Kinase Inhibitor
- Efficacy of Cytotoxic Agents against Human Tumor Xenografts Is Markedly Enhanced By Coadministration of ZD1839 (Iressa), an Inhibitor of EGFR Tyrosine Kinase
- In Vivo Antitumor Activity of SU11248, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial Growth Factor and Platelet-derived Growth Factor Receptors: Determination of a Pharmacokinetic/Pharmacodynamic Relationship
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
- A Novel Approach in the Treatment of Cancer: Targeting the Epidermal Growth Factor Receptor